Lantern Pharma’s Remarkable Phase 2 Trial Update in Advanced Lung Cancer
Lantern Pharma’s ongoing HARMONICâ„¢ clinical trial has yielded promising early results. The trial examines the efficacy of LP-300, a...
Surge in Septic Shock Care: Vivacelle’s Innovative Approach
We had the chance to sit down with Harven DeShield, Chief Executive Officer and Co-founder of Vivacelle Bio. We...
COYA Therapeutics’ Novel Patent Filing: Expanding Pipeline in Alzheimer’s Disease
COYA 301, a recombinant human low-dose interleukin-2 (LD IL-2), and Glucagon-Like Peptide-1 receptor agonists (GLP-1 RAs) have demonstrated potential...
SanBio Wins Approval for Akuugo as Chronic TBI Treatment
SanBio Co. Ltd has received approval in Japan for “AKUUGO® Suspension for Intracranial Implantation,” a groundbreaking cell-based therapy for...
Jemperli Expands Approval to All Adult Endometrial Cancer Patients
The FDA has granted approval for Jemperli (dostarlimab-gxly) in combination with chemotherapy (carboplatin and paclitaxel) followed by Jemperli alone...
AI-Empowered Immunotherapy Partnership: A Transformative Leap in Cancer Care
BostonGene and Takeda collaborate on research studies focused on immuno-oncology. Their partnership aims to enhance clinical trial design, improve...
FDA and Big Pharma Discuss Updates on Decentralized Clinical Trials
The 2024 DIA conference session on decentralized clinical trials (DCTs) brought together leading experts from various sectors to discuss...
Unlearn’s AI-Powered Clinical Trials with AbbVie and Johnson & Johnson
Unlearn, an AI company, showcased the impact of its technology in two poster sessions at the Alzheimer’s Association International...
New Study: Alzheimer’s Progression Explored with Revolutionary Cell Platform
Groundbreaking research has led to a novel model using human induced pluripotent stem cell (iPSC)-derived cortical neurons to understand...
Evolus Obtains Approval For Botox in Australia
Evolus, a performance beauty company focused on aesthetics, has launched operations in Australia by introducing Nuceiva (prabotulinumtoxinA). This marks...